{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-26-026769","form_type":"8-K","ticker":"MLAB","cik":"0000724004","company_name":"MESA LABORATORIES INC /CO/","filed_at":"2026-08-10T20:03:03+00:00","discovered_at":"2026-08-10T20:04:00.362311+00:00","generated_at":"2026-08-10T20:04:12.161591+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Mesa Labs Q1 revenue +1.0%; AOI up 19.5%; net income down on FX","bullets":["Total revenues $60.1M, up 1.0% YoY; core organic growth 0.4%, first positive quarter.","Operating income up 129% to $7.0M; non-GAAP AOI ex unusual items up 19.5% to $15.4M.","Net income down 40.3% to $2.8M ($0.49 diluted) on FX losses vs prior-year gains.","Repaid $8.7M debt; total net leverage ratio 1.85, below 2.0 target.","CEO Siddhartha Kadia (joined ~100 days ago) to give full-year guidance in November."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-26-026769","json":"https://secwatch.observer/filing/0001437749-26-026769.json","markdown":"https://secwatch.observer/filing/0001437749-26-026769.md","text":"https://secwatch.observer/filing/0001437749-26-026769.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/724004/000143774926026769/0001437749-26-026769-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/724004/000143774926026769/mlab20260807_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-10T20:04:12.161591+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}